Total Payments
$6,352
2024 Payments
$852.42
Companies
26
Transactions
208
Medicare Patients
3,479
Medicare Billing
$259,941
Payment Breakdown by Category
Food & Beverage$6,109 (96.2%)
Education$242.83 (3.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,109 | 201 | 96.2% |
| Education | $242.83 | 7 | 3.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $2,297 | 47 | $0 (2024) |
| BIOTRONIK INC. | $606.36 | 16 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $566.10 | 29 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $524.04 | 21 | $0 (2023) |
| Amgen Inc. | $511.73 | 24 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $310.43 | 5 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $176.79 | 8 | $0 (2024) |
| Abbott Laboratories | $156.24 | 2 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $132.47 | 7 | $0 (2024) |
| Medtronic, Inc. | $128.96 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $852.42 | 31 | Boston Scientific Corporation ($261.43) |
| 2023 | $1,041 | 43 | Boston Scientific Corporation ($240.54) |
| 2022 | $589.48 | 29 | BOSTON SCIENTIFIC CORPORATION ($328.19) |
| 2021 | $1,189 | 26 | BOSTON SCIENTIFIC CORPORATION ($621.04) |
| 2020 | $612.88 | 17 | Boston Scientific Corporation ($275.85) |
| 2019 | $1,313 | 44 | Boston Scientific Corporation ($302.83) |
| 2018 | $753.84 | 18 | BOSTON SCIENTIFIC CORPORATION ($267.15) |
All Payment Transactions
208 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $16.59 | General |
| Category: Obesity | ||||||
| 11/18/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $23.08 | General |
| Category: DIABETES | ||||||
| 11/16/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $22.36 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/31/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $24.74 | General |
| Category: Obesity | ||||||
| 10/28/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.33 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/22/2024 | Medtronic, Inc. | MICRA (Device) | Food and Beverage | In-kind items and services | $19.19 | General |
| Category: Pacemakers | ||||||
| 09/20/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $24.43 | General |
| Category: Cardiovascular | ||||||
| 08/06/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.19 | General |
| Category: Obesity | ||||||
| 07/31/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $23.82 | General |
| Category: Cardiology | ||||||
| 07/08/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.19 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/02/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug), FARXIGA | Food and Beverage | In-kind items and services | $36.81 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/27/2024 | Inari Medical, Inc. | FLOWTRIEVER CATHETER, S (Device), CT THROMBECTOMY SYSTEM KIT | Food and Beverage | In-kind items and services | $96.52 | General |
| Category: VTE | ||||||
| 06/19/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.41 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/11/2024 | Alnylam Pharmaceuticals Inc. | AMVUTTRA (Drug) | Food and Beverage | In-kind items and services | $13.12 | General |
| Category: Genetic Disease | ||||||
| 06/10/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $15.36 | General |
| Category: Cardiology | ||||||
| 05/16/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $20.10 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/01/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.48 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/17/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $24.21 | General |
| Category: Cardiology | ||||||
| 04/15/2024 | Celgene Corporation | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $13.23 | General |
| Category: Cardiovascular | ||||||
| 04/12/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $97.11 | General |
| Category: General - Balloon Catheters_ICG | ||||||
| 04/08/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $14.44 | General |
| Category: Cardiology | ||||||
| 04/06/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $53.18 | General |
| Category: General - Balloon Catheters_ICG | ||||||
| 03/20/2024 | Boston Scientific Corporation | SYNERGY (Device) | Food and Beverage | In-kind items and services | $12.97 | General |
| Category: SYNERGY_IC | ||||||
| 03/13/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.24 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/12/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $13.60 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 30 | 2,016 | 2,530 | $669,108 | $155,945 |
| 2022 | 21 | 1,111 | 1,355 | $358,909 | $87,004 |
| 2021 | 8 | 352 | 373 | $58,661 | $16,992 |
Total Patients
3,479
Total Services
4,258
Medicare Billing
$259,941
Procedure Codes
64
All Medicare Procedures & Services
64 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 227 | 230 | $145,595 | $32,056 | 22.0% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 103 | 103 | $102,043 | $27,831 | 27.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 189 | 225 | $62,550 | $19,507 | 31.2% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 92 | 362 | $77,830 | $15,309 | 19.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 91 | 91 | $38,857 | $10,602 | 27.3% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 103 | 205 | $53,640 | $5,547 | 10.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 38 | 47 | $17,484 | $5,440 | 31.1% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 109 | 111 | $26,751 | $5,117 | 19.1% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 101 | 101 | $18,180 | $4,806 | 26.4% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Office | 2023 | 26 | 26 | $18,824 | $4,540 | 24.1% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 388 | 436 | $10,028 | $2,656 | 26.5% |
| 93224 | Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | Office | 2023 | 49 | 54 | $16,362 | $2,608 | 15.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 14 | 14 | $7,462 | $2,350 | 31.5% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 11 | 11 | $8,987 | $2,263 | 25.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 34 | 34 | $6,392 | $1,797 | 28.1% |
| 93268 | Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring and review and report by health care professional | Office | 2023 | 15 | 16 | $10,016 | $1,790 | 17.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 13 | 13 | $6,851 | $1,464 | 21.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 120 | 140 | $7,280 | $1,384 | 19.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 16 | 23 | $4,324 | $1,376 | 31.8% |
| 92960 | External shock to heart to regulate heart beat | Facility | 2023 | 14 | 15 | $4,995 | $1,221 | 24.4% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 13 | 15 | $4,350 | $1,159 | 26.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 13 | 13 | $4,641 | $1,108 | 23.9% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 16 | 16 | $2,576 | $950.40 | 36.9% |
| 93320 | Ultrasound of heart blood flow, valves and chambers | Office | 2023 | 21 | 21 | $3,864 | $830.97 | 21.5% |
| 93244 | Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 35 | 36 | $1,866 | $621.52 | 33.3% |
About Dr. Stephen Wall, M.D
Dr. Stephen Wall, M.D is a Cardiovascular Disease healthcare provider based in Sacramento, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/25/2015. The National Provider Identifier (NPI) number assigned to this provider is 1033503388.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stephen Wall, M.D has received a total of $6,352 in payments from pharmaceutical and medical device companies, with $852.42 received in 2024. These payments were reported across 208 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($6,109).
As a Medicare-enrolled provider, Wall has provided services to 3,479 Medicare beneficiaries, totaling 4,258 services with total Medicare billing of $259,941. Data is available for 3 years (2021–2023), covering 64 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Sacramento, CA
- Active Since 03/25/2015
- Last Updated 10/18/2018
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1033503388
Products in Payments
- SYNERGY (Device) $1,101
- LifeVest (Device) $524.04
- Repatha (Biological) $366.09
- ELIQUIS (Drug) $322.73
- XARELTO (Drug) $310.43
- WATCHMAN (Device) $278.52
- FARXIGA (Drug) $247.66
- ROTABLATOR (Device) $247.24
- RESONATE (Device) $242.99
- BRILINTA (Drug) $148.00
- Corlanor (Drug) $145.64
- JARDIANCE (Drug) $136.38
- ASSURITY (Device) $135.56
- iLab Ultrasound Imaging System (Device) $130.41
- BioMonitor (Device) $128.96
- WOLVERINE (Device) $110.79
- Edora (Device) $104.86
- FLOWTRIEVER CATHETER, S (Device) $96.52
- ATTAIN COMMAND + SUREVALVE (Device) $93.60
- ENTRESTO (Drug) $79.14
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Sacramento
Jason Rogers, M.d, M.D
Cardiovascular Disease — Payments: $4.4M
Cardiovascular Disease $4.4M
Gagan Singh, M.d, M.D
Cardiovascular Disease — Payments: $1.2M
Cardiovascular Disease $1.2M
William Bommer, M.d, M.D
Cardiovascular Disease — Payments: $501,159
Cardiovascular Disease $501,159
Dr. Edris Aman, M.d, M.D
Cardiovascular Disease — Payments: $361,130
Cardiovascular Disease $361,130
Munir Janmohamed, Md, MD
Cardiovascular Disease — Payments: $309,883
Cardiovascular Disease $309,883
Jeffrey Southard, M.d, M.D
Cardiovascular Disease — Payments: $280,346
Cardiovascular Disease $280,346